---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-055559"
form_type: "8-K"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2023-07-07T23:59:59+00:00"
generated_at: "2026-06-13T10:55:12.208881+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma shareholders approve reverse stock split authority up to 1-for-15

## Summary
- Special meeting held July 7, 2023; quorum of 19,044,974 shares (57.57% voting power) present.
- Proposal approved with 18,631,480 votes for, 413,494 against, 0 abstentions.
- Board authorized to effect one or more reverse splits up to 1-for-15 at any time before July 7, 2024.
- Company intends to implement a reverse split in the near future; will file a subsequent 8-K.
- No further details on split ratio or timing provided.

## SEC filing metadata
- accession: 0001213900-23-055559
- form_type: 8-K
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2023-07-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390023055559/0001213900-23-055559-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390023055559/ea181507-8k_abvcbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-055559
- JSON: https://secwatch.observer/filing/0001213900-23-055559.json
- Plain text: https://secwatch.observer/filing/0001213900-23-055559.txt

## Key facts
- Shareholder Votes
  ABVC BIOPHARMA, INC. shareholders approved Reverse stock split authorization at the 2023-07-07 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2023-07-07
  source text: To approve granting the Board the authority to effect one or more reverse splits of the Company’s issued and outstanding Common Stock by a ratio of up to one-for-fifteen, at any time or from time to time, prior to July 7, 2024, with the exact timing and amount of each split to be determined by the Board in its sole discretion and file a Certificate of Amendment to the Company’s Articles of Incorporation regarding same.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1173313/000121390023055559/0001213900-23-055559-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.